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Objective: This study was undertaken to determine the demographic, anatomic,
institutional, and surgical risk factors associated with outcomes after the Norwood
operation.
Methods: A total of 710 of 985 neonates with critical aortic stenosis or atresia
enrolled in a prospective 29-institution study between 1994 and 2000 underwent the
Norwood operation. Admission echocardiograms were independently reviewed for
64% of neonates. Competing risks analyses were constructed for outcomes after
Norwood operation and after cavopulmonary shunt. Incremental risk factors for
outcome events were sought.
Results: Overall survivals after the Norwood operation were 72%, 60%, and 54% at
1 month, 1 year, and 5 years, respectively. According to competing risks analysis,
97% of neonates reached a subsequent transition state by 18 months after Norwood
operation, consisting of death (37%), cavopulmonary shunt (58%), or other state
(2%, cardiac transplantation, biventricular repair, or Fontan operation). Risk factors
for death occurring before subsequent transition included patient-specific variables
(lower birth weight, smaller ascending aorta, older age at Norwood operation),
institutional variables (institutions enrolling 10 neonates, two institutions enroll-
ing 40 neonates), and procedural variables (shunt originating from aorta, longer
circulatory arrest time, and management of the ascending aorta). Of neonates
undergoing cavopulmonary shunt, 91% had reached a subsequent transition state by
6 years after cavopulmonary shunt, consisting of Fontan operation (79%), death
(9%), or cardiac transplantation (3%). Risk factors for death occurring before
subsequent transition included younger age at cavopulmonary shunt and need for
right atrioventricular valve repair.
Conclusions: Competing risks analysis defines the prevalence of the various out-
comes after Norwood operation and predicts improved outcomes with successful
modification of controllable risk factors.
Hypoplastic left heart syndrome (HLHS) remains the most commoncongenital cardiac lesion causing death within the first year afterbirth.1 The vital anatomic component of classic HLHS is under-development of the left ventricle-aorta complex, resulting in crit-ical aortic valve stenosis (AVS) or aortic valve atresia (AVA) anda variable degree of hypoplasia of other left-sided heart struc-
tures.2 Since the early 1980s, when Norwood and coworkers3,4 popularized surgical
palliation of HLHS, the prognosis for infants born with this lesion has dramatically
improved from certain early death to an appreciable prospect of survival.
Previous reports from the Congenital Heart Surgeons Society (CHSS) on neo-
nates with AVA or AVS have compared the selection of initial therapeutic ap-
proaches and their outcomes for each group.5-7 Treatment options for neonates with
AVA and for those with AVS not amenable to biventricular repair include staged
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surgical palliation and orthotopic cardiac transplantation.
Staged surgical palliation has become the preferred option
rather than cardiac transplantation in most institutions be-
cause of low donor organ supply, waiting list attrition,
unknown long-term graft function and survival, necessity
for chronic immunosuppressive therapy, and improvements
in results after staged palliation.
Many reports address the outcomes for neonates with
HLHS undergoing the Norwood operation and often incor-
porate variants of HLHS that are known to carry a better
prognosis than classic HLHS.8 Few have analyzed out-
comes at each stage of palliation in the same cohort of
patients, and none have used competing risks methodology.
Although interstage attrition after the Norwood operation is
an acknowledged problem, few reports have attempted to
elucidate risk factors for death occurring after hospital dis-
charge but before subsequent stages.9,10 Because of these
considerations, we constructed a competing risks analysis
with data from a multi-institutional, longitudinal study to
determine the prevalence of the various outcomes after the
Norwood operation, to demonstrate the changes in risk with
time associated with these outcomes, and to elucidate the
demographic, anatomic, institutional, and surgical risk fac-
tors associated with each outcome.
Patients and Methods
Between January 1994 and December 2000, a total of 710 neonates
underwent staged surgical palliation via the Norwood operation.
This group was extracted from a pool of 985 neonates with critical
left ventricular outflow tract obstruction (AVS, n  422) or AVA
(n  563) entered into simultaneous prospective studies. The
neonates were managed at 29 member institutions of the CHSS.
Institutional enrolment ranged from 1 to 155 neonates, with 9
institutions enrolling more than 40 neonates and 18 enrolling 10 or
fewer. Participation in the study and submission of patient infor-
mation was voluntary and confidential. Consent from each family
was obtained consistent with individual institutional policy. Ethics
approval for the CHSS Data Center is obtained annually from the
institutional review board of the Hospital for Sick Children in
Toronto.
Study Population
Neonates younger than 30 days at the time of admission to a
participating institution were eligible for inclusion. Morphologic
criteria for entry included concordant atrioventricular and ven-
triculoarterial connections and either AVA or critical AVS. The
surgical criterion for inclusion in this analysis was a Norwood
operation. AVA was considered to be the absence of blood flow
across the aortic valve, as determined by color Doppler echocar-
diography. AVS was considered to be important left ventricular
outflow tract obstruction or hypoplasia, with demonstrated patency
of the aortic valve and either moderately or severely reduced left
ventricular function at admission or presence of duct-dependent
systemic perfusion.
Norwood Operation
Aortic reconstruction was performed with classic patch aortoplasty
in 80%, with the Brawn-Mee modification11,12 (distal aortic tran-
section and arch reconstruction without prosthetic material) in 9%,
with transection of the ascending aorta with reimplantation into the
neoaorta in 9%, and with a modified technique consisting of
pulmonary artery-arch anastomosis without proximal or distal aor-
tic transection in 2%. The systemic-pulmonary arterial shunt most
commonly originated from the innominate artery (84%), followed
by the subclavian artery (7%), aorta (6%), and carotid artery (2%).
Mean shunt diameter indexed to body weight was 1.15  0.22
mm/kg. A 3.5-mm shunt was most commonly used (64%). A
classic Blalock-Taussig shunt was used in 1% of the neonates.
Median age at the Norwood operation was 6 days (range 1-140
days), and median weight was 3.2 kg (range 1.5-5.2 kg).
Data Collection
Copies of medical records, including admission, diagnostic, and
procedure reports, were requested for initial and subsequent as-
sessments, admissions, or procedures and abstracted into a data-
base by the Data Center and members of the CHSS. Detailed
morphologic data were obtained by reviewing initial (before im-
portant intervention) echocardiographic videotape recordings from
participating institutions. The protocol for this independent,
blinded review has been described previously elsewhere.5 Among
the study population, initial echocardiograms were made available
for 76% of neonates with AVS and for 57% of those with AVA.
Follow-up
The physician, family, or guardian of each child not known to have
died has been contacted yearly since cohort inception to ascertain
clinical status and any intervening problems or procedures. How-
ever, contact by the Data Center is dependent on institutional
review board and parental consent at each institution, limiting
potential follow-up. The most recent cross-sectional follow-up was
conducted between May and August 2001 and was 76% complete.
If cross-sectional follow-up data from 2000 are included for the
183 children without 2001 follow-up, 91% had cross-sectional
follow-up data within 1 year of this analysis.
Data Analysis
Goals of this analysis include defining the prevalence of various
outcomes after the Norwood operation and determining the risk
factors associated with each outcome. All analyses were performed
with SAS statistical software (version 8; SAS Institute, Inc, Cary,
NC). Data are given as frequency, median with range, or mean 
SD as appropriate.
Missing data. The number of nonmissing values is given for
descriptive statistics. If weight, height, or body surface area was
not reported, informative imputation was based on available pa-
tient characteristics and standard percentile growth charts, assum-
ing that the patient’s height and weight percentiles were concor-
dant. If ascending aortic diameter was not available from
echocardiographic review, values obtained from the operative
record were used (n  114). Inclusion of surgical values did not
significantly affect the mean aortic diameter in either the AVA
group (2.4 0.9 mm vs. 2.5 0.9 mm for echocardiography only,
P  .20) or the AVS group (5.3  1.8 mm vs. 5.4  1.8 mm for
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echocardiography only, P  .44). Missing value indicator vari-
ables were created for missing continuous variables (eg, echocar-
diographic variables and circulatory arrest time), and the mean
value of available information was imputed (noninformative im-
putation). In multivariable analyses, the relevant missing value
indicator variables were carried to adjust for the possibility that
patients with a given missing value may be different with respect
to outcome from those in whom the value is not missing.
Competing risks after the Norwood operation. The following
mutually exclusive states after the Norwood operation were des-
ignated: death, cavopulmonary shunt (CPS), other state (cardiac
transplantation, biventricular repair in similar fashion to that de-
scribed by Yasui and colleagues,13 and Fontan operation), and
survival without transition to a subsequent state. Rate of transition
(hazard function) from the initial state to each competing state was
determined, and these were synthesized to yield the proportion of
neonates reaching defined transitional states at any given time after
the Norwood operation.14
Non-risk-adjusted nonparametric estimates of the time-related
freedom from each state were plotted as Kaplan-Meier estimates.
Modeling the hazard function, searching for multiple phases of
risk, and elucidating the characteristic equation of each phase
allowed computation of parametric estimates of time-related free-
dom from each chosen outcome event.15
Demographic, institutional, morphologic, and surgical factors
associated with each outcome after the Norwood operation were
sought by multivariable analysis of the parametric models with the
variables noted in Appendix Table 1. Variables associated with 5
or fewer events were eliminated from consideration to minimize
the risk of model overdetermination. Bootstrap bagging was the
primary tool for multivariable analysis, because it nearly perfectly
balances the risks of false-positive and false-negative identification
of risk factors.16 For this, 1000 bootstrap data sets of the same size
as the original data set were analyzed by automated stepwise
regression with an inclusion criterion of P .1. This was followed
by cluster analysis, with the results to yield risk factors occurring
in 50% or more of the analyses and the most common occurring
transformation of each continuous variable selected. To this were
added other variables and interactions of interest, with the caveat
of displaying the reliability of each factor according to the bagging
analysis. Reported parameter estimates represent the contribution
of a variable to the overall model. Variable increments and math-
ematic transformations affect interpretation of the contributions
and are reported where applicable. The multivariable models were
solved for multiple combinations of risk factors to explore the
magnitude of effect of these factors and predict outcomes for
neonates with given characteristics.
Competing risks after CPS. A second competing risks of
events analysis was constructed to illustrate outcomes after CPS.
The following mutually exclusive states were designated: death,
Fontan operation, cardiac transplantation, and survival without
transition to subsequent state. Risk factors for rate of transition to
these states were determined as described earlier with incorpora-
tion of additional variables applicable to this stage of palliation
(Appendix Table 2).
Competing risks after the Fontan operation. Survival after
the Fontan operation was examined. Because of the small number
of terminal events, survival free of cardiac transplantation was
considered. Risk factors were sought from Fontan-specific vari-
ables (Appendix Table 2).
Results
Overall survivals to last follow-up after Norwood palliation
were 72% at 1 month, 63% at 6 months, 60% at 1 year, and
54% at 5 years.
Competing Risks After Norwood Operation
Outcomes occurring after the Norwood operation are shown
in time-independent fashion in Figure 1. Neonates transi-
tioned to two major competing states: death (n  261) and
CPS (n  377). Smaller numbers underwent direct transi-
tion to cardiac transplantation (n  8), biventricular repair
(n  4), and Fontan operation (n  1). Fifty-nine infants
remain alive without transition to one of these states.
Transition to any of these states was time related, and the
rate at which each transition occurred varies with interval
from the Norwood operation (Figure 2, A). Early after the
Norwood operation, there was a single rapidly declining
hazard phase for death occurring before transition to a
subsequent state. Within 3 months, rate of transition to CPS
began to predominate, and it peaked just beyond 6 months.
There was a low, continuous risk of undergoing other op-
erations, mainly cardiac transplantation.
With these transition rates used simultaneously, time-
dependent prevalence of each state was calculated by the
competing risks analysis (Figure 2, B). Six months after the
Norwood operation, prevalence in various states included
CPS (31%), death before a subsequent transition (37%), and
other state (1%). The remaining 31% were surviving in the
initial state. Between 6 months and 1 year after the Nor-
Figure 1. Flow chart illustrating subsequent procedures for 710
neonates with AVA or AVS who underwent Norwood operation.
Prevalences of death after each procedure are indicated within
parentheses. HTX, Cardiac transplantation; BVR, biventricular re-
pair consisting of Damus-Kaye-Stansel aortopulmonary connec-
tion, baffling of left ventricular outflow to neoaorta, and Rastelli-
type connection from right ventricle to pulmonary artery.
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wood operation, prevalence of death before subsequent
transition did not appreciably change; however, prevalence
of CPS increased to 57%.
Risk factors for post-Norwood mortality. Incremental
risk factors for increased time-related death after the Nor-
wood operation but before transition to any other state
included patient-specific factors (lower birth weight, older
age at Norwood, and smaller size of ascending aorta),
surgical factors (shunt origin from neoaorta and longer
circulatory arrest time), and institutional factors (institutions
enrolling fewer than 10 neonates and 2 institutions enrolling
more than 40 neonates; Table 1). The effects on survival of
birth weight, age at Norwood operation, aortic origin of the
shunt, and circulatory arrest time are shown in Appendix
Figure 1. When institutions were excluded from risk factor
selection, the technique of transecting and reimplanting the
ascending aorta into the neoaorta was associated with in-
creased survival in neonates with a small ascending aorta.
Solving the multivariable equation while adjusting for other
risk factors suggested a survival benefit for neonates with an
ascending aorta measuring 3 mm or less if the ascending
aorta was transected and reimplanted into the neoaorta
(Figure 3).
Of 512 patients surviving to be discharged from the
hospital, 63 (12%) died in the interim between discharge
and subsequent staging. The absence of a constant or late
Figure 2. Competing risks analysis of outcomes after Norwood
operation in 710 neonates with AVS or AVA. All patients began
alive at Norwood operation and thereafter could transition to one
of three mutually exclusive outcomes: death, CPS, and other
outcomes (including cardiac transplantation, biventricular repair,
and Fontan operation). Solid lines represent parametric point
estimates; dashed lines enclose 70% confidence interval. At each
point in time, sum of percentages of neonates in all categories is
100%. A, Competing hazard functions for each outcome. B, Pro-
portion of neonates (expressed as percentage of total) in each of
four categories at any given time after undergoing Norwood
operation.
TABLE 1. Incremental risk factors for time-related death
after Norwood operation with and without institution en-
tered as a variable
Variable
Parameter
estimate*
(SE)
P
value
Reliability
(%)
Including institution
Lower birth weight (per 1-kg
increment)
0.44 0.14 .01 53
Older age at operation (per
1-wk increment)
0.091 0.035 .01 83
Longer total circulatory
arrest time† (per 10-min
increment)
0.0012 0.00031 .001 90
Smaller ascending aortic
dimension‡ (per 1-mm
increment)
0.49 0.13 .001 86
Shunt originating from aorta 0.51 0.23 .03 52
Institution enrolling 10
neonates
.01 78
Institution H 1.01 0.30 .001 79
Institution I 0.48 0.22 .03 43
Excluding institution
Lower birth weight (per
1-kg increment)
0.42 0.14 .01 71
Older age at operation
(per 1-wk increment)
0.12 0.036 .01 89
Longer total circulatory
arrest time† (per 10-min
increment)
0.0013 0.00031 .001 97
Smaller ascending aortic
dimension‡ (per 1-mm
increment)
0.64 0.13 .001 89
Nonreimplantation of
ascending aorta into
neoaorta
1.68 0.86 .05 39
Interaction term between
ascending aortic diameter
and nonreimplantation
1.48 .99 .14 —
Shunt origin from aorta 0.35 0.24 .13 55
*For a single early hazard phase adjusted for missing arch reconstruction
technique in the model excluding institution.
†Entered after square transformation.
‡Entered after logarithmic transformation.
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phase of hazard for death occurring before subsequent op-
eration indicates that the risk factors defined previously
were applicable both to hospital mortality and interval mor-
tality before subsequent staging. To confirm this observa-
tion, the multivariable equation was solved on the condition
of hospital discharge to predict the occurrence of interval
mortality. The observed time-related prevalence of interval
mortality was accurately predicted by the current parametric
model (Figure 4).
CPS as an intermediate stage. A total of 377 infants
underwent CPS at a median age of 6 months (range 1-28
months) as an intermediate stage to Fontan completion.
Factors associated with earlier CPS included two patient-
specific factors (lower birth weight and smaller z score of
mitral valve diameter) and two procedural variables (lower
post-Norwood oxygen saturation and smaller shunt size
indexed to body weight; Table 2). Impact of shunt size on
transition to CPS was greatest for lower weight neonates
(Figure 5). The effect of post-Norwood oxygen saturation
on transition to CPS is illustrated in Figure 6. Two institu-
tions were predictive of earlier CPS, and two institutions
were predictive of later CPS (Table 2).
Prediction of outcomes for various levels of risk. To
illustrate the difference in outcomes for patients undergoing
the Norwood operation affected by various patient and
procedural characteristics, the multivariable equations for
the major transitions were solved. The resulting competing
risks curves demonstrate the difference in predicted out-
comes for neonates having characteristics consistent with
the upper and lower 25th risk percentiles (Figure 7).
Competing Risks After CPS
Death after CPS but before undergoing subsequent stages
occurred in 28 infants (Figure 1). Of 349 survivors of CPS,
Figure 3. Risk-adjusted survival after Norwood operation but
before transition to another state (deaths occurring after transi-
tion not included in this determination) for varying aortic sizes
stratified according to transection and reimplantation of ascend-
ing aorta. Multivariable equation was solved twice (with and
without transection and reimplantation), each time entering mean
values for the other predictors. Survival benefit is illustrated for
neonates with ascending aorta less then 3 mm in diameter if
ascending aorta is transected and reimplanted into neoaorta.
Solid lines represent parametric determination of survival for
given ascending aortic size; dashed lines enclose 70% confi-
dence interval.
Figure 4. Comparison of predicted versus observed survival to
next transition after hospital discharge after Norwood operation.
Circles represent Kaplan-Meier estimate for observed survival at
each death; solid line represents parametric prediction of con-
tinuous point estimates; dashed lines enclose 70% confidence
interval. Parametric model accurately predicts time-related oc-
currence of death in interval between hospital discharge after
Norwood operation but before transition to subsequent state.
TABLE 2. Incremental risk factors for time-related transi-
tion from Norwood circulation to CPS with and without
institution as risk factor
Variable
Parameter
estimate*
(SE)
P
value
Reliability
(%)
Including institution
Lower post-Norwood oxygen
saturation† (per 5% increment)
0.31 0.16 .056 50
Lower z score of mitral valve 0.054 0.021 .01 49
Institution J 0.85 0.13 .001 100
Institution I 0.53 0.20 .01 70
Not institution G 1.03 0.22 .001 99
Not institution K 0.72 0.33 .03 60
Excluding institution
Lower post-Norwood oxygen
saturation† (per 5% increment)
0.43 0.15 .01 77
Smaller indexed shunt size†
(per 0.1 mm/kg increment)
0.16 0.046 .01 64
Lower birth weight (per 1-kg
increment)
0.31 0.15 .04 53
Lower z score of mitral valve 0.040 0.021 .06 47
*For a single early hazard phase.
†Entered after logarithmic transformation.
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199 progressed to the Fontan operation. Cardiac transplan-
tation was performed in 8 children after CPS. No transition
to a subsequent state has occurred in 142 children. Exami-
nation of the competing hazard functions for these states
reveals a rapidly declining early phase for death occurring
before subsequent state (Figure 8, A). Between 9 months
and 18 months after CPS, a rapid increase in the rate of
transition to the Fontan operation occurred, with subsequent
slow decline during the next 4 years. On the basis of these
hazard functions, the time-related prevalences of these
states after CPS were determined (Figure 8, B).
Risk factors for post-CPS mortality. Incremental risk
factors for time-related death after CPS included younger
age at CPS and repair of right atrioventricular valve insuf-
ficiency at CPS (Table 3). The magnitude of the effect of
age at CPS on mortality increased with decreasing age
(Figure 9). No institution was identified as significant pre-
dictor.
Conversion to Fontan circulation. Fontan operation
was performed at a median age of 2 years (range 1-6 years).
Incremental factors associated with transition to Fontan
operation are listed in Table 4.
Figure 5. Risk-adjusted freedoms from transition to CPS at 18
months after the Norwood operation stratified by absolute shunt
diameter for indicated range of neonatal weight at operation.
Effect of shunt size on transition to CPS was greatest in lower
weight neonates, with smaller shunts resulting in increased rates
of transition.
Figure 6. Risk-adjusted freedom from transition to CPS stratified
by post-Norwood oxygen saturation, as predicted by solving
multivariable equation with other predictor variables set at mean
values. Lines represent parametric determination of continuous
point estimates of transition.
Figure 7. Creation of competing risks analysis of outcomes for
two neonates, representing 25th and 75th risk percentiles, after
undergoing Norwood operation. Solid lines represent ; dashed
lines enclose 70% confidence interval. A, 3.6-kg neonate with
4.7-mm ascending aorta and mitral valve z score of 4.3 under-
going surgery at 4 days of age with following surgical charac-
teristics: total circulatory arrest time of 41 minutes indexed shunt
size (absolute) of 1.25 mm/kg (4.5 mm), nonaortic shunt origin,
ascending aorta not transected for reimplantation, and post-
Norwood oxygen saturation of 80%. B, 2.8-kg neonate with 2-mm
ascending aorta and mitral valve z score of 7.4 undergoing
surgery at 9 days of age with following surgical characteristics:
total circulatory arrest time 55 minutes, indexed shunt size (ab-
solute) of 1.0 mm/kg (3 mm), nonaortic shunt origin, ascending
aorta transected and reimplanted, and post-Norwood oxygen
saturation of 75%.
Ashburn et al Surgery for Congenital Heart Disease
The Journal of Thoracic and Cardiovascular Surgery ● Volume 125, Number 5 1075
CH
D
Outcome After Fontan Operation
Five children died after the Fontan operation, and 3 have
required cardiac transplantation. Survival free of cardiac
transplantation after the Fontan operation was 96% at 2
years (Appendix Figure 2). Because of the small numbers of
deaths and transplants, risk factors for these events could
not be determined.
Discussion
Principal Findings
The prognosis of neonates born with HLHS has dramati-
cally improved relative to its dismal natural history. How-
ever, the competing risks analysis reported here confirms
that mortality associated with staged surgical palliation of
neonates with HLHS remains heavily concentrated around
Figure 8. Competing risks analysis of outcomes after CPS among
377 infants who survived Norwood operation and subsequently
underwent CPS. All patients began alive at CPS and thereafter
could transition to one of three designated outcomes: Fontan
operation, death, or cardiac transplantation. Solid lines represent
parametric determination of continuous point estimates; dashed
lines enclose 70% confidence interval. A, Competing hazard func-
tions for each outcome. B, Proportions of infants (expressed as
percentage of total) in each of four categories at any given time.
Sum of percentages of infants in all categories is 100%. HTx,
Cardiac transplantation.
TABLE 3. Incremental risk factors for time-related transi-
tion to death after CPS
Variable
Parameter
estimate* (SE) P value
Reliability
(%)
Younger age at CPS†
(per 3 month increment)
0.48 0.10 .001 93
Atrioventricular valve
repair at CPS
1.46 0.59 .01 61
*For a single late hazard phase.
†Entered after logarithmic transformation.
Figure 9. Risk-adjusted percentage survival after CPS stratified
according to patient age at CPS. Lines represent parametric point
estimates of survival for specified patient age.
TABLE 4. Incremental risk factors for time-related transi-
tion from CPS to Fontan circulation with and without in-
stitution as a risk factor
Variable
Parameter
estimate*
(SE)
P
value
Reliability
(%)
Including institution
Earlier date of birth (per
1-y increment)
0.22 0.073 .01 96
Higher weight at CPS (per
1-kg increment)
0.27 0.079 .01 91
Hemi-Fontan connection 0.44 0.19 .02 59
Institution D 1.74 0.37 .001 98
Institution J 0.50 0.21 .02 68
Not institution A 0.59 0.33 .08 30
Excluding institution
Earlier date of birth (per
1-y increment)
0.22 0.073 .01 76
Higher weight at CPS (per
1-kg increment)
0.25 0.074 .01 65
Hemi-Fontan connection 0.83 0.15 .001 86
*For a single early hazard phase adjusted for missing information for
weight at CPS in model excluding institution.
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the time of the Norwood operation. Outcomes beyond con-
version to CPS are excellent. The analysis reveals that
patient, institutional, and procedural factors influence both
goals of early palliation: survival and successful transition
to subsequent intermediate and final states.
The overall post-Norwood survivals reported in this
multi-institutional study are comparable to those in two
earlier multi-institutional reports and several reports by
high-volume centers.8,17-21 Our early mortality data are also
similar to those reported by the Society of Thoracic Sur-
geons National Congenital Heart Surgery Database, in
which the operative mortality for 187 neonates undergoing
the Norwood operation between 1994 and 1997 was 27%.22
A number of reports from individual institutions have
examined post-Norwood mortality and its associated risk
factors.17,20,21,23 Several of these studies have shown signif-
icant improvement in survival with time. Mahle and col-
leagues20 from the Children’s Hospital of Philadelphia re-
ported the outcomes of 840 infants undergoing the Norwood
operation between 1984 and 1999 in the largest single
institutional series published to date.20 Their center had
improvements in hospital and 3-year survivals between
1984 to 1988 (56% and 28%, respectively) and 1995 to
1998 (71% and 66%, respectively). We did not demonstrate
later date of birth or date of surgery to be a significant factor
associated with post-Norwood survival, signifying no trend
toward improved survival during the study’s 6-year span.
We found increasing age at Norwood operation to be a
risk factor for mortality in a continuous manner. Mahle and
associates20 found that age older than 14 days was a risk
factor, and Bove and Lloyd24 described increased risk for
neonates older than 30 days. The potential for a neonate to
undergo the Norwood operation days after birth is at least
partially dependent on his or her postnatal clinical status.
Tworetzky and colleagues25 correlated improved clinical
status and significantly younger age at operation with pre-
natal diagnosis. These observations emphasize the impor-
tance of early perinatal optimization of the neonate with the
goal of early, but not emergency, Norwood operation.
Several groups have described the increased risk posed
by low birth weight.9,17,20,21 Weinstein and coworkers26
reported an early mortality of 49% for 67 neonates smaller
than 2.5 kg, compared with an overall early mortality of
26% at their institution. Delaying staged surgical recon-
struction for the prospect of increasing neonatal weight is
offset by the risk imposed by older age at operation. Al-
though cardiac transplantation represents an alternative
therapy for these neonates, there have been mixed reports
regarding low birth weight as a risk factor for cardiac
transplantation. A previous CHSS study6 found lower birth
weight to be a risk factor for infants with AVA entered into
a transplant protocol, whereas a report from Razzouk and
colleagues27 at Loma Linda on a larger group of patients
with HLHS did not find low birth weight to be a risk factor.
At present, low birth weight is an immutable patient-spe-
cific factor for which no optimal solution is known.
There have been differing reports regarding the impact of
ascending aortic size on survival.5,6,9,20,28 Our data show an
association between smaller ascending aortic size and post-
Norwood mortality. The most important implication of the
tiny ascending aorta involves compromise of coronary
blood flow.9 Anatomic subtype has also been purported to
be a risk factor.29 Although neonates with AVA had signif-
icantly smaller ascending aortas than those with AVS, nei-
ther AVA nor AVS emerged as significant risk factors.
These data suggest that antegrade coronary flow potentially
resulting from patency of the left-sided valves does not
diminish the impact of the tiny ascending aorta. Technical
modifications aimed at creating a durable, maximally patent
coronary connection are expected to benefit neonates with a
diminutive (3 mm) ascending aorta.
Diastolic coronary blood flow has been shown to be
impaired after the Norwood operation.30 A systemic-pulmo-
nary shunt originating from the aorta may reduce coronary
perfusion to a greater degree than a more distal shunt by
further reducing neoaortic diastolic blood pressure and in-
creasing competing flow to the pulmonary arteries. That this
phenomenon would not be well tolerated in the post-Norwood
period is supported by previous reports of reduced baseline
and maximal coronary blood flows, particularly in the set-
ting of volume loading.31 Shunt origin from the aorta as a
risk factor for mortality has important implications in neo-
nates with anomalous origin of the right subclavian artery.
Because the carotid artery is often not suitable for shunt origin,
alternate surgical technique is necessary in these neonates to
decrease the risk conferred by aortic shunt origin.
Use of total circulatory arrest has been implicated in
reducing neurodevelopmental outcomes of children who
undergo staged palliation for HLHS.32 Although our study
did not assess neurologic outcomes, we found that increas-
ing circulatory arrest time was associated with higher mor-
tality after the Norwood operation. These findings illustrate
the importance of minimizing the exposure of the neonate to
ischemia. Although we observed no survival benefit asso-
ciated with use of modified perfusion techniques, further
data are needed to support the inference that modified
regional perfusion could result in both survival and neuro-
developmental benefits.
Unexpected death after discharge from the surgical in-
stitution has been reported to range in prevalence from 4%
to 15%.10,21 Factors linked to interstage attrition by previous
authors include perioperative arrhythmia, earlier date of
operation, and atresia of the aortic and mitral valves.9,10 We
found a 12% mortality before CPS for hospital survivors of
the Norwood operation. Our model accurately predicted the
occurrence of these deaths, indicating that the same set of
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risk factors explain post-Norwood deaths whether they oc-
cur before or after hospital discharge. This finding is not
surprising when one considers that impaired coronary per-
fusion or extremes of pulmonary blood flow accounted for
63% of deaths in a large postmortem series of Norwood
nonsurvivors.33 Although not specifically examined as a risk
factor in our study, obstruction at the site of distal aortic
arch reconstruction may also contribute to post-Norwood
attrition. Nonetheless, the frequency of these deaths is of
concern and indicates a need to improve the postdischarge
evaluation and home management of these infants. Close
echocardiographic surveillance of the central circulation in
the near postoperative term could detect, and thus allow
early correction of, hemodynamically important lesions in
neonates with these risk factors.
Competing Risks
Use of competing risks analysis allowed us to evaluate the
efficiency with which survivors of the Norwood operation
can be transitioned to the intermediate state of CPS. Al-
though optimal timing of CPS in this population remains
elusive, our data reveal that younger age is a risk factor for
CPS mortality. One might consider that younger age at CPS
is simply a marker for poorer progress after the Norwood
operation, because we have demonstrated that survivors
among neonates at increased risk for death also transition
more rapidly to CPS. However, we found that postoperative
oxygen saturation and indexed shunt size, which in addition
to total cardiac output are related to the quantity of pulmo-
nary blood flow, are predictors of the transition to CPS.
Conversely, we did not find shunt size to be a factor asso-
ciated with post-Norwood mortality. One might infer from
these data that a larger shunt size indexed to body weight
(1.15-1.25 mm/kg) and higher post-Norwood oxygen satu-
ration (70%-80%) predict older age and therefore increased
survival at CPS. However, further studies are needed to
determine whether the survival benefit at CPS for older
infants is offset by the deleterious effects of the longer
duration of shunt-dependent physiology.
Study Limitations
The multi-institutional nature of this study and its large
cohort of patients provide a broad view of the status of
staged surgical palliation for neonates with critical AVS or
AVA. Although a comprehensive set of variables was used,
missing data points are a potential weakness of the study.
With currently available data, we could not explore the
hemodynamic status of infants before subsequent staging.
Incorporation of such data could allow determination of the
optimal age for performing CPS and Fontan completion.
Also, a combined analysis of outcomes after the Norwood
operation and after cardiac transplantation could potentially
define factors that would direct neonates toward the more
beneficial pathway.
Conclusions
We have shown that patient, institutional, and procedural
variables affect outcomes after the Norwood operation. So-
lution of the competing risks model for various levels of risk
demonstrates that successful modification of these risk fac-
tors predicts better survival and more efficient transition to
subsequent stages, which may lead to better outcomes for a
larger proportion of neonates with HLHS undergoing the
Norwood operation.
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Appendix TABLE 1. Selected patient characteristics relat-
ing to the Norwood operation
Variable No. Missing Value
Demographic characteristics
Birth weight (kg, median and range) 388 382 3.2 (1.5-5.0)
Gender (female/male) 710 0 256:454
Noncardiac anomaly (No.) 710 0 68 (10%)
Prematurity (No.) 710 0 6 (1%)
Morphologic characteristics
Echocardiogram reviewed (No.) 710 0 454 (64%)
AVA (No.) 710 0 449 (63%)
Critical AVS (No.) 710 0 261 (37%)
Ascending aortic diameter (mm, mean
 SD)
635 75 3.5 1.9
AVA 2.4 0.8
Critical AVS 5.3 1.8
Aortic coarctation (No.) 437 273 252 (58%)
Mitral stenosis (No.) 541 169 327 (60%)
Mitral atresia (No.) 541 169 214 (40%)
Mitral valve z score (mean  SD)
Anterior-posterior dimension 610 1006.2 2.7
Lateral dimension 612 987.2 2.8
Tricuspid valve z score (mean  SD)
Anterior-posterior dimension 631 791.1 1.7
Lateral dimension 634 760.6 1.8
Atrial septal defect gradient (mean 
SD)
211 489 3.7 2.3
Interrupted aortic arch (No.) 271 339 4 (1%)
Moderate or large ventricular septal
defect (No.)
310 400 20 (6%)
Tricuspid regurgitation (No.) 389 321
None 200 (50%)
Mild 131 (33%)
Moderate or greater 58 (17%)
Any endocardial fibroelastosis (No.) 254 456 143 (56%)
Persistent left superior vena cava
(No.)
710 0 51 (7%)
Anomalous pulmonary venous
drainage (No.)
710 0 25 (4%)
Coronary artery anomaly (No.) 710 0 46 (6%)
Tricuspid valve abnormality (No.) 710 0 17 (2%)
Pulmonary valve abnormality (No.) 710 0 20 (3%)
Procedural characteristics (Norwood
operation)
Age at surgery(d, median and range) 709 1 6 (1-140)
Weight at surgery (kg, median and
range)
501 209 3.2 (1.5-5.2)
Modified cerebral perfusion (No.) 679 31 38 (6%)
Lowest cooling temperature (°C, mean
 SD)
495 215 18 (1.5)
Atrial septectomy (No.) 684 26 667 (98%)
Distal aorta transected (No.) 691 19 89 (13%)
Absolute shunt diameter (No.) 679 31
3.0 mm 53 (8%)
3.5 mm 433 (64%)
4.0 mm 193 (28%)
Shunt diameter indexed to body
weight (mm/kg, mean  SD)
481 229 1.15 0.22
Shunt origin (No.) 680 30
Aorta 41 (6%)
(Continued on next page)
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Discussion
Dr James S. Tweddell (Milwaukee, Wis). It is an honor to
discuss this outstanding and well-presented contribution by Ash-
burn and colleagues. This multi-institutional analysis of patients
undergoing Norwood palliation of HLHS has confirmed important
patient risk factors and identified important procedural variables.
Further, Ashburn and colleagues have shown that these risk factors
persist into the interstage period. This is an important contribution.
In our experience the period of greatest risk is now that between
the Norwood procedure and subsequent stage II palliation.
I have the following questions for Dr Ashburn:
1. The period covered by the study is one that has seen dra-
matic improvement in the outcome of patients undergoing
the Norwood procedure. In our own program we have
experienced something of a sea change in the management
of this group of patients. From 1994 to the present, looking
at only 108 true hypoplasts, or the anatomic category pre-
sented here, our survival at 1 month was 83%. But if we
look at the 78 patients operated on in our program from
1996 to the present, which includes the uniform use of
venous oxygen saturation monitoring and afterload reduc-
tion with -blockade, we have a 1-month survival of 96%
with subsequent survivals to 1 and 5 years of 79% and 77%.
2. In the study presented today, 102 deaths occurred within 48
hours of the Norwood procedure. This represents 14% of the
study population. Since the application of venous oxygen
saturation monitoring and the use of afterload reduction, we
have had no deaths within 48 hours.
3. Did you look at any postoperative management variables in
their analysis, specifically, the use of an open sternum
strategy, sedation and paralysis, ventilator management,
medical gas manipulation, vasodilators, or inotropes? The
contributions of these factors might have shed as much or
more light on the outcome than the factors chosen for
analysis.
4. We have also been concerned with the small ascending aorta
and agree that the tripartite connection of the diminutive
ascending aorta, pulmonary root and the neo-ascending
aorta may result in distortion or kinking, resulting in coro-
nary insufficiency. We have dealt with this by cutting back
on the pulmonary root and ascending aorta and placing that
connection at or below the sinotubular junction of the pul-
monary valve and away from the connection of the neo-
ascending aorta and the pulmonary root. Was this or a
similar strategy used in any of the patients in the study?
Would you care to conjecture on the impact of this operative
approach on outcome?
5. This study is unique in that several strategies for arch
reconstruction were used. Did you gain any insight into the
Appendix TABLE 2. Selected patient characteristics relat-
ing to subsequent CPS and Fontan operation
Variable No. Missing Value
CPS
Age at operation (mo,
median and range)
376 1 6 (1-28)
Weight at operation (kg,
mean  SD)
238 139 6.0 1.2
Cardiopulmonary bypass
(No.)
352 25 338 (96%)
Total circulatory arrest (No.) 346 31 171 (50%)
Total circulatory arrest time
(min, mean  SD)
130 41 37 14
Glenn connection (No.) 376 1 214 (57%)
Hemi-Fontan connection
(No.)
376 1 163 (43%)
Unilateral connection (No.) 354 23 332 (94%)
Bilateral connection (No.) 354 23 22 (6%)
Pulmonary arterioplasty (No.) 346 31 221 (64%)
Right 173 (50%)
Left 205 (59%)
Atrioventricular valve repair
(No.)
341 36 22 (6%)
Fontan operation
Age at surgery (y, median
and range)
2 (1-6)
Connection (No.) 186 13
Extracardiac 27 (15%)
Lateral tunnel 159 (85%)
Connection material (No.) 174 25
Prosthetic 161 (93%)
Biologic 13 (7%)
Fenestration (No.) 186 13 157 (84%)
Mean fenestration size (mm,
mean  SD)
147 10 4 1
Atrial septectomy (No.) 172 27 20 (12%)
Atrioventricular valve repair
(No.)
175 24 26 (15%)
Pulmonary arterioplasty (No.) 171 28
Right 29 (17%)
Left 27 (16%)
Appendix TABLE 1. Cont’d
Variable No. Missing Value
Innominate artery 574 (84%)
Subclavian artery 47 (7%)
Carotid artery 15 (2%)
Other 3 (1%)
Aortic reconstruction (No.) 689 21
Classic patch aortoplasty 549 (80%)
Brawn-Mee modification 60 (9%)
Ascending aortic transection
with reimplantation
64 (9%)
Modified pulmonary artery-arch
anastomosis
16 (2%)
Aortic augmentation (No.) 690 20
Patch 564 (82%)
Tube 20 (3%)
None 106 (15%)
Aortic augmentation material (No.) 584 20
Polytetrafluoroethylene 4 (1%)
Homograft 574 (98%)
Pericardium 6 (1%)
Post-Norwood oxygen saturation
(%, mean  SD)
344 366 77 7
Total circulatory arrest time (min,
mean  SD)
539 171 49 16
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impact of these arch reconstruction strategies on the devel-
opment of recurrent or residual arch obstruction?
6. Finally, could you expand on the choice of competing risk
analysis and the advantage of this type of analysis relative to
other forms of multivariable analysis?
Dr Ashburn. We certainly are aware of the excellent results
being presented from your institution, as well as from a number of
other institutions, with particular improvement in recent years.
Regarding improvement through time in the outcomes of these
children, we did not find date of operation to be a statistically
significant predictor of survival between 1994 and 2000. I
noticed that you included in your breakdown 1996 to the
present, and it may be that in the last 2 years since our study
ended that the rate of improvement, considering new technol-
ogy such as what your group has introduced, has made a
difference in recent outcomes. Certainly, compared across de-
cades of time there have been dramatic improvements reported
in the literature, and one hopes that further improvement will
continue.
We did not incorporate postoperative variables, such as hemo-
dynamic, inotrope, blood gas, or ventilator management variables,
into the analysis. I cannot comment on the impact of those factors
on outcomes.
In a subsequent review and subanalysis, 77 infants were found
to require reintervention for recurrent or residual distal aortic arch
obstruction. According to the Kaplan-Meier method, the freedoms
from reintervention for arch obstruction were 96%, 87%, and 84%
at 3 months, 6 months, and 1 year, respectively. In a preliminary
Appendix Figure 1. Risk-adjusted percent survival after the Norwood operation before transition to a subsequent
state stratified by birth weight (A), age at operation (B), aortic or nonaortic origin of systemic-pulmonary shunt (C),
and total circulatory arrest time (D). Solid lines represent parametric point estimates; dashed lines enclose 70%
confidence interval.
Appendix Figure 2. Survival free of cardiac transplantation after
Fontan operation. Numbers in parentheses represent patients
remaining at risk at each time point.
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analysis, the technique of arch reconstruction did not arise as a risk
factor for reintervention for recurrent arch obstruction. Although
reintervention for recurrent coarctation was not shown to have a
statistically significant impact on the overall survival after the
Norwood operation, we believe that this issue requires further
study.
The study revealed a strong logarithmic association of ascend-
ing aortic size with post-Norwood mortality. The technique of
aortopulmonary anastomosis most commonly used in our popula-
tion was the classic patch aortoplasty, in which the arch and
ascending aorta are opened and connected to the neoaorta with an
extensive patch. We do not have data on the cutback modification
that you describe. However, I think the study shows that technical
modifications that result in less kinking and distortion, as you
suggest, and a more durable, patent coronary connection can be
expected to improve survival of neonates with an ascending aorta
smaller than 3 mm.
Regarding the competing risks analysis methodology, perhaps
the biggest advantage is that it allows us to see what is happening
to the overall group of patients at any given point in time. Use of
competing risks also gives a more accurate representation of the
prevalences of outcome events. It is really the time relatedness of
how these events occur that is of interest. It’s not uncommon to see
raw mortality figures represented in an article, but we try to take
that a step further and not only represent the mortality but explain
the timing of the mortality and how it relates to other transitions
that these patients may undergo. For instance, birth weight is a
significant risk factor for death after the Norwood operation. By
competing risks analysis, we also discovered that birth weight is a
predictor of rate of transition to CPS. Those are the types of
relationships that wouldn’t come out of a different type of analysis.
Dr Thomas L. Spray (Philadelphia, Pa). The virtue of the
multi-institutional CHSS studies is the fact that they give you a
snapshot, if you will, of practice across a broad range of different
institutions. But one of the disadvantages is the fact that a few
institutions can significantly skew the data. For example, I wonder
how many institutions there were that used the reimplantation
strategy for the small ascending aorta. If you took a few institu-
tions that used that strategy with very good results, would that
skew the data to suggest that reimplantation was in fact favorable,
when in fact other institutions—maybe many more institutions—
where reimplantation wasn’t used as a technique contributed many
more patients with slightly worse outcomes? For example, if you
took what I would call low-risk institutions for the standard re-
construction and compared those with the institutions that used
reimplantation strategies, would you still find that reimplantation
decreased the risk of early death?
In addition, I also wonder how you measured the ascending
aortic diameter. It depends a lot on whether there is an independent
observer looking at all patients to measure the diameter by echo-
cardiography or whether it’s a surgical measurement in the oper-
ating room and whether it’s an estimate by the surgeon or by
probing or whatever. The difference between 1 mm and 2 mm
(100%) may be pretty subjective by estimation in the operating
room.
Dr Ashburn. The morphologic variables were obtained by an
independent blinded echocardiographic tape review. In the case of
ascending aortic dimension, echocardiographic review values were
preferentially used and account for 82% of the measurements.
Where echocardiographic values were not available, ascending
aortic dimension was obtained from the operative record, and such
cases account for 18% of the measurements. Inclusion of operative
values did not result in a statistically significant change in the
mean values for either AVS or AVA when compared with echo-
cardiographic values alone.
With regard to your question about ascending aortic reimplan-
tation, eight institutions enrolled neonates in whom this technical
modification was used. We did not perform risk adjustment for
individual institutions, nor did we compare institutional outcomes
with one another, so I cannot comment on the possible differential
impact of ascending aortic management on the survivals at high-
risk and low-risk institutions.
Dr Christian P. R. Brizard (Melbourne, Australia). I was
surprised to hear that you found that young age for the CPS was a
risk factor for death after CPS. In our institution we have been able
to significantly reduce the attrition rate in the waiting period for the
CPS by bringing forward the CPS to 3 months of age, with no
increase in the mortality or morbidity of the CPS procedure. How
do you explain your result? Also, from your statistical analysis,
can you extrapolate to determine what would be the optimal age
for the CPS?
Dr Ashburn. Your second question is of great interest to us,
and we had hoped that we could answer it from this analysis.
Unfortunately, we have not been able to put that analysis together
at this point. I might add that incorporating hemodynamic data
from the pre-CPS catheterization into such an analysis could be
important in quantifying the time dependence of deleterious effects
of shunt-dependent single-ventricle physiology in this these neo-
nates.
With respect to why younger age at CPS increases risk, I think
that it goes back to the risk factors for that transition. In our study
the patients who were at risk for undergoing an earlier CPS also
tended to be the patients who were at high risk for death after the
Norwood operation. So those high-risk neonates who survived the
Norwood operation but fared poorly were also more likely to do
poorly at the time of CPS.
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